Trial Profile
Effect of nucleoside analog and peginterferon alfa 2a sequential therapy on patients with chronic hepatitis B
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Adefovir dipivoxil; Entecavir; Lamivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- 02 Jul 2014 New trial record